Evil, I agree. As shareholders, some of us lon
Post# of 148187
I agree. As shareholders, some of us long time, we are entitled to the truth and some honest work from the company employees.
Management and the board are being paid salaries (some large) to advance the company toward trials and, hopefully, drug approvals.
I understand that biotech is a risky proposition and success is far from granted. However, we can expect to know what progress has been achieved during all these months to accomplish these objectives.
A nothing-burger is unacceptable. The only thing I am demanding is to know what has been done all this time (successfully or otherwise), what will be done and what the hurdles are.
We need to know where we are. We are tired of taking the "mushroom treatment" (being fed with you-know-what while being kept on the dark) for another 5.
Hopefully we will get some positive realities.